Drupal for pharma and life sciences companies

Why Drupal fits pharmaceutical and life sciences websites

Drupal can host a multi-market, multi-approval website model in infrastructure the company controls. A pharmaceutical company typically runs brand sites, product pages and disease-area content for many countries, and each piece of regulated content passes through its own medical, legal and regulatory review chain. Drupal handles this through content modeling rather than through separate sites: review states, reviewer roles and approval history can be attached to the content types themselves, and the same core can serve many language and market sites from one codebase. The hosting, database and backups stay in the company's own cloud accounts or data centers, which matters when the site sits near patient-facing information and when data privacy reviews ask where content and user records live. The fit depends on three design decisions made before any build starts. The first is the content model for approvals: which entities need a review state, how a claim or safety statement is linked to its approved source document, and whether a market can publish a locally adapted version without losing the global reference. The second is multisite governance: which settings, menus and content types are shared across markets, which are owned locally, and who may change each. The third is the integration boundary: forms that collect adverse event or patient data should be kept out of the CMS and handed to systems the company already governs, and the site should only receive what it must display. Each of these shapes the module list, so a Drupal partner should confirm them in a written discovery before estimating scope. Drupal is licensed under GPL-2.0-or-later and there is no paid edition of Drupal itself, so the license fee is zero. Cost sits in the build, the hosting and the support that keeps the site patched. The Drupal core release schedule shows that Drupal 10 reaches end of life on December 9, 2026, so any plan should include a dated upgrade to Drupal 11 or 12 and ask a partner to price that work separately from launch. When requesting a quote, ask how contributed modules will be vetted, who monitors security advisories and who pays for each.

Which life sciences requirements shape a Drupal build

This table compares each regulatory or framework requirement relevant to pharma and life sciences sites with its source and the build decision it drives in Drupal. Read each row as a question for counsel and your compliance lead, not as a certification: the requirement defines what must be confirmed before scoping starts.

Requirement	Source and scope	Build consequence and what to confirm
HIPAA Security Rule	45 CFR Part 164 Subpart C applies only to covered entities and business associates handling ePHI (45 CFR 164.302)	Confirm first whether any Drupal site or form receives patient data. If not, keep health data out of the CMS. If yes, the business associate contract under 45 CFR 164.314 shapes hosting, logging and incident reporting.
21 CFR Part 11	Electronic records and electronic signatures used in FDA-regulated activities (21 CFR Part 11)	Applies where review workflows create regulated records or signatures. Confirm with quality and regulatory teams which content states need audit trails, signed approvals and access controls, and whether the Drupal build is in scope at all.
GDPR Articles 32 and 34	Security of processing (Article 32) and communication of personal data breaches to data subjects (Article 34) under Regulation (EU) 2016/679	The CNIL fined Hopital Prive de la Loire EUR 500,000 on 3 September 2026 for external access without VPN or multi-factor authentication and for access control ignoring the care team's need to know. Plan MFA for editors, least-privilege roles and a tested breach notification procedure.
NIS2 Annex I	Directive (EU) 2022/2555 lists medicinal product research and development and manufacturers of basic pharmaceutical products as sectors of high criticality	Confirm whether your EU entities fall within scope and national transposition rules. Expect questions on patch cadence, incident reporting and supplier security, which affect how the Drupal stack is patched and monitored.
European Health Data Space	Regulation (EU) 2025/327 on the European Health Data Space	Confirm with counsel whether any Drupal component handles health data subject to its provisions. Brand sites that only publish product information usually sit outside it, while patient or healthcare professional services may not.
Drupal security support	Drupal core security releases follow a scheduled cycle, and Drupal 10 reaches end of life on December 9, 2026 (Drupal core release schedule)	Regulatory evidence of timely patching depends on running a supported version. Plan the Drupal 11 path or a Drupal 12 readiness check before end of life dates, and keep patch records for assessors.
Hosting and data location	Regulators and sponsors may ask where personal and health-related data is stored and processed	Choose hosting and multisite layouts that match data residency commitments. Confirm which markets, cloud regions and subprocessors are approved before the architecture is fixed.

How multi-market brand and product sites are structured

One Drupal codebase and one content repository serve the global brand site and its market sections as subsites or language-and-region paths. The central team controls the content model, navigation, templates and most pages, while market teams edit a defined set of local pages and translations. This model keeps governance in one place and makes cross-market reporting and consistent brand expression straightforward, but every market shares release timing and editorial queues.

Language and hreflang: Each market path carries its own language and region variants, and hreflang annotations must reference every alternate. Confirm how your multisite setup generates these tags so they stay correct when a market is added.
Shared content: Global pages, brand assets and product core data are authored once and inherited, with overrides allowed only where a market needs them.
Local ownership: Market teams own localized pages and regional offers, with publishing rights limited to their path.
Autonomy trade-off: Markets have less freedom to change layouts or launch campaigns quickly, but the brand stays consistent and audit evidence is produced once.
Operational load: A single release train means one upgrade and one test cycle, which lowers recurring cost but raises the impact of any defect.

Check with your legal and regulatory teams which product claims can be overridden locally before you agree the override rules.

Which Drupal modules and integrations matter for pharma

Pharma sites carry review states, multiple market sites, workforce and partner access, and privacy obligations that the default Drupal setup does not cover on its own. The cards below cover the modules and configuration decisions that shape those requirements, and each one should be confirmed against the Drupal and module versions your project targets.

Review states for medical, legal and regulatory

Medical, legal and regulatory review usually means several sign-off stages that a single publish button does not model. Plan the workflow states, who may move content between them, and which roles can publish, before building anything. Content moderation in Drupal core can express these states, but the transitions, notifications and reviewer groups are project decisions your team and ours must document. Confirm that the editorial workflow module pattern you choose supports your exact approval chain in the Drupal release you target.

Multisite and language layouts for markets

Brand and product sites for many markets need a decision between one multilingual site, several sites sharing a codebase, or a hybrid. Each layout changes how content is shared, how translations are governed and how local legal text is kept separate from global copy. Settle the market governance model first, then choose the layout. Check how your chosen multisite approach handles shared modules, updates and per-market configuration in the hosting setup you plan to run.

SAML sign-in for workforce accounts

The samlauth module lets a Drupal site act as a SAML service provider, so medical, legal and content staff can sign in with the company identity provider instead of local passwords. Decide how group or role claims map to Drupal roles, how accounts are provisioned and removed when staff leave, and whether local login remains for emergency access. Confirm the module version against your Drupal release, since its latest stable release supports Drupal 10.3 and later and Drupal 11.

OpenID Connect for external reviewers

Agencies, medical writers and partner reviewers often need access to review queues without a company directory account. The OpenID Connect module can authenticate users from an external provider and create accounts on first sign-in, which needs tight control. Decide which providers are trusted, which roles new external accounts receive by default, and how access ends when a review contract finishes. Confirm the provider list and client types your project needs against the module's current release.

Audit logging and revision history

Review evidence depends on knowing who changed what, when, and which approved version was live. Drupal revision history and the Database Logging module (dblog) record content changes and events, but retention, export and tamper resistance are not automatic. Define which events must be kept, how long they are retained, and where logs are shipped for review. If your organization operates under 21 CFR Part 11 or similar expectations, confirm with your quality team which records and signatures count as evidence before the build starts.

Consent and cookie management

Brand sites that run analytics, embedded video or patient-facing tools across markets need consent behavior that differs by jurisdiction. A consent management module or a consent layer in front of the site can gate scripts until a visitor agrees, and the rules must match each market's privacy requirements. Map which scripts load on which pages, decide where consent is stored, and test that blocked scripts stay blocked. Have privacy counsel confirm the legal basis for each market before choosing a module.

How a pharma Drupal rollout runs in phases

The sequence moves from market and review-chain discovery to a proven pilot market, then to staged onboarding of further markets and a maintenance routine. Each phase closes with a written output that the company's own teams can check before the next phase starts. How long each phase takes depends on the number of markets and the agreed written scope.

Map markets, review chains and content owners
DeployOpen works with brand, regulatory, medical, legal and local affiliate leads to record each market, language, product family and the approval chain that content must pass before publication. The team also confirms which data types must stay out of the CMS, such as individual patient data, and who signs off on each rule. The step closes with a market and review-chain inventory that the company has approved in writing.
Design the content model and approval workflow
Working from the inventory, DeployOpen models content types for products, indications, claims, references and local adaptations, and defines which fields are global and which are market-specific. Workflow states, reviewer roles and the points where content is locked for audit are designed with the company's review owners. The output is a content model document and a workflow specification that reviewers have walked through with sample content.
Set up identity, roles and access boundaries
The team connects the site to the company's identity provider where it is needed, sets up roles per market and per reviewer group, and limits editors to the sites and content types they own. Administrative access, service accounts and secrets handling are documented and tested, including removal of access when people change roles. The step ends with an access matrix and test results showing that users can only reach what the matrix allows.
Build and test a pilot market
DeployOpen builds one market site end to end on the agreed content model, with custom modules where the workflow needs them, multilingual settings for that market and the chosen hosting setup. The pilot is tested with real reviewers using the company's own content, covering approval routing, rollback, search and accessibility checks. Completion is a signed pilot acceptance record and a list of open defects with agreed owners.
Collect validation evidence with the quality team
Where the company treats the site as a computerized system under its quality framework, DeployOpen and the quality team agree which requirements apply, such as those in 21 CFR Part 11 for electronic records and signatures if the company is subject to it. The team produces specifications, test scripts, test results, configuration baselines and change records in a form the company's quality function reviews. The output is a validation package that the company's quality function has accepted or has commented on.
Onboard further markets in stages
Each further market is added using the pilot as the template, with its own languages, reviewers and local content, and goes live only after its reviewers complete the same acceptance checks. Changes to the shared model go through the change control agreed in earlier phases, so a fix made for one market is tested against the others. Each market closes with its own acceptance record and an updated access matrix.
Hand over and run post-launch maintenance
DeployOpen hands over runbooks, deployment steps, backup and restore procedures and the monitoring setup, and trains the company's administrators and content operations staff. Security advisories, core and contributed module updates and periodic access reviews are run on the schedule set in the written support agreement. The handover closes with a signed operations record and a maintenance calendar that the company's own team can follow.

Keeping patient and personal data out of the CMS

The most effective control for a pharmaceutical brand site is to keep patient and personal health data out of Drupal entirely. A product information site, a medical information request form and a patient support landing page can be built so that the CMS only handles general content, while adverse event reports, patient identifiers and clinical details go to systems designed for them. In practice this means a data boundary decision made during content modeling: every webform, contact block and login area is listed with the data it collects, and anything health-related is routed to a vendor system outside the Drupal database. The Webform and Search API configuration should then be reviewed against that list before launch, so that fields such as patient_id or free-text symptom boxes do not appear in submission tables, search indexes or logs.

Where data does reach Drupal, the hosting and access design matters as much as the forms. The GDPR requires appropriate technical measures and breach notification duties under Articles 32 and 34, and NIS2 lists medicinal product research and development and manufacturers of basic pharmaceutical products among high-criticality sectors, which means security incident reporting obligations may apply to some companies in the group. The CNIL fined Hopital Prive de la Loire EUR 500,000 on 3 September 2026 after finding that external access to its patient record system lacked VPN and multi-factor authentication and that access control ignored the care team's need to know. For a Drupal estate, the equivalent questions are who can reach the editing interface from outside the network, whether multi-factor authentication is enforced for every editor and administrator account, and whether roles grant access only to the markets and content each person needs. Confirm these with your legal and security teams, since the applicable obligations depend on where you operate.

If a partner touches electronic protected health information for a US covered entity or on your behalf, the HIPAA Security Rule may require a business associate contract under 45 CFR 164.314(a)(2)(i). That contract must require compliance with the Security Rule, flow the same terms to subcontractors handling ePHI and require reporting of security incidents to the covered entity. Ask whether any DeployOpen or hosting work would involve ePHI before the contract is drafted, and document the answer. Note that there is no HIPAA certification: HHS states that no Security Rule standard requires certification. DeployOpen plans and implements controls such as access reviews, logging and backup procedures and prepares evidence for your own assessments, but it does not issue audit reports, attestations or certifications. Independent auditors and certification bodies provide those.

What pharma teams ask before hiring a Drupal partner

What drives the cost of a multi-market Drupal build?

The cost follows the number of markets, languages, sites and review paths you need, more than the Drupal licence, which is free. Drupal and contributed modules are GPL-2.0-or-later, so your spend goes to people and infrastructure: discovery and content modeling, custom modules, theming, integrations with your CRM and identity provider, migration, testing and hosting. Ask for a written quote that splits one-time build work from recurring items such as hosting, security updates, module maintenance and support retainers. Each market or language variant, each approval workflow and each integration should appear as a separate line so you can see what a change to scope will cost. DeployOpen does not publish prices; a quote follows from the written scope.

Can our internal team run a Drupal platform after launch?

Often yes, if the team has Drupal skills and a clear operating model, but the work does not end at launch. Plan for someone to own the release cadence: Drupal core bugfix releases come on the first Wednesday of each month and security releases on the third Wednesday, according to the Drupal core release schedule. Your team also needs owners for hosting, backups, monitoring, content governance and module updates. Ask a partner to document the platform, run a handover and agree which tasks stay internal and which move to a retainer. Confirm your staffing against that list before you decide to build in-house or outsource.

How long does a Drupal build for life sciences take?

Duration depends on scope, not on a fixed template, so ask for a timeline tied to written deliverables. The main drivers are the number of markets and languages, how many content types and review states you need, the number of integrations (identity, CRM, medical information systems, translation tools), the volume of content to migrate, and how many approval rounds your medical, legal and regulatory reviewers require. Your own decision speed matters too: slow sign-off on content models or review chains extends every phase. A credible plan breaks the work into discovery, build, integration, migration, testing and a controlled launch per market, with each phase's exit criteria stated. Confirm these phases in the quote rather than accepting a single end date.

What must our company provide for a Drupal project?

A partner can build the platform only as fast as your organization makes decisions and grants access. Typical inputs include named content owners for each market, a documented review chain for medical, legal and regulatory sign-off, access to your identity provider for SSO testing, and a decision maker who can approve the content model and launch criteria. You should also provide hosting accounts or data center access, test accounts for integrations, and the legal position on data processing for any personal data. Ask the partner to list these inputs in the quote with an owner and a needed-by date for each, so gaps show up before the build starts.

Do our Drupal 7 sites need migration, and who supports them meanwhile?

Yes, Drupal 7 sites need a planned migration because they cannot be updated in place to Drupal 10 or later. Drupal.org documentation explains that sites are migrated into a new site using the core Migrate, Migrate Drupal and Migrate Drupal UI modules or Drush, and that themes must be rebuilt. Drupal 7 security support ended on January 5, 2025, according to Drupal.org. For sites that cannot migrate yet, the Drupal Association's Extended Security Support Provider Program lists HeroDevs and Tag1 Consulting as certified vendors. Treat that as a bridge with its own contract and cost, and ask any partner to state the exit date from extended support in writing.

Can a Drupal site be certified as HIPAA or 21 CFR Part 11 compliant?

No, there is no HIPAA certification, and no vendor or partner can certify a site as HIPAA compliant. HHS states that no Security Rule standard requires certification and that private certifications do not stop HHS from later finding a violation. The HHS Office for Civil Rights enforces the rule through complaints, compliance reviews and audits. For 21 CFR Part 11, the question is whether your electronic records and signatures meet the regulation in your validated environment, which your quality team and auditors assess. A partner can prepare configuration, access controls, audit trails and evidence, and your business associate contracts must reflect any protected health information. Ask for a written statement of what the partner delivers as evidence and what remains with your auditors.

What should a written Drupal quote for pharma include?

A useful quote lists the scope by market, language and site, with each deliverable named. Ask for separate sections for discovery, content modeling, custom modules, theming, each integration, data migration, testing, accessibility checks, security review, launch support and handover. Each section should show who does the work, what the client provides, and the acceptance criteria. Require a line for recurring costs such as hosting, updates and support retainers, and a statement of assumptions, including the number of review rounds and content volumes. Finally, ask how changes are priced after signature. DeployOpen works from a written scope with agreed deliverables and timelines before work starts.

Compliance considerations that change the build

Pharmaceutical and life sciences teams rarely face one rulebook. Health data, regulated records, EU privacy duties and security patching each shape how a Drupal site is hosted, integrated and signed off. The cards below mark where those obligations change the build and what your regulatory and quality team must confirm before scope is fixed.

HIPAA scope and business associate terms

The HIPAA Security Rule applies to covered entities and their business associates for electronic protected health information they handle. A Drupal site only falls in scope if it creates, receives, maintains or transmits ePHI, such as patient support forms or program enrollment. If it does, 45 CFR 164.314 requires a business associate contract that flows Security Rule terms down to subcontractors and requires incident reporting. Confirm with legal whether any hosting, support or module vendor will sign that contract before any ePHI is in scope.

Proposed Security Rule revision

HHS proposed a major Security Rule revision in January 2025, and it is not yet final. Build against the current rule, but keep logging, encryption, access reviews and asset inventory configurable so a final rule does not force a rebuild. Ask your compliance lead to track the Unified Agenda timing and to name who decides when a proposed requirement becomes a backlog item.

HITRUST as an optional assessment

HITRUST is a private assessment framework that many life sciences buyers request in vendor questionnaires. It is not a legal requirement, and HHS states that no Security Rule standard requires certification. Decide early whether a HITRUST assessment is expected by a customer or partner, because that choice changes evidence collection, control mapping and the assessor you engage. Confirm the required assessment type and scope with the buyer rather than assuming one.

21 CFR Part 11 records and signatures

Where a Drupal site stores or approves regulated records, such as controlled review sign-offs or evidence supporting submissions, 21 CFR Part 11 sets expectations for electronic records, electronic signatures and audit trails. Content revisions, reviewer identity and approval timestamps must be attributable and protected from silent change. Confirm with your quality team which content is a regulated record, which needs a validated workflow, and who owns that validation.

GDPR and NIS2 duties

Sites serving EU audiences process personal data under GDPR, including Article 32 security of processing and Article 34 notification of breaches. NIS2 lists medicinal product research and development and manufacturers of basic pharmaceutical products among high-criticality health sectors, which can bring incident reporting and supplier security duties. Map which entities in your group fall under each regime, and confirm consent, data residency and vendor processing terms with your privacy office before the first data flow is designed.

Drupal security advisories and patch windows

The Drupal Security Team publishes advisories with CVE identifiers and risk scores, and security releases arrive on the third Wednesday of the month. Your team must be able to apply core and contributed module patches inside the window your risk policy sets, and record each decision as evidence. Confirm who receives advisories, who approves emergency deployments, and whether a retainer covers out-of-hours patching in your environment.

Planning upgrades for long-lived pharma sites

Plan the upgrade path before the next feature build starts, because Drupal 10 reaches end of life on December 9, 2026, and Drupal 12 is scheduled for the week of December 7, 2026. For a pharma estate with many brand, product and regional sites, that date leaves little room for a single cutover. Inventory every site in the multisite estate, record its Drupal core version, and confirm which contributed modules and themes have releases for the target version. Each major version also raises the PHP floor: Drupal 10 requires PHP 8.1 or later, Drupal 11 requires PHP 8.3 or later and Drupal 12 requires PHP 8.5 or later. Ask your hosting team whether the current PHP runtime, container images and managed platform images can move to those versions, since a PHP upgrade is often the longest item on the critical path.

Anchor the upgrade calendar to the core release cadence. Bugfix releases ship on the first Wednesday of each month and security releases on the third Wednesday, so reserve a standing window that can absorb a security patch within days of release without displacing a planned upgrade. Each upgrade candidate should pass through a staging environment that mirrors production configuration, then through regression tests on the regulated paths: approval workflows, medical and legal review states, audit logging, consent records and locale-specific content. Your quality team needs evidence from those runs, so record the test scripts, dated results, the Drupal and module versions tested, and who approved the change. Keep this material in the validated system record so an inspector can trace each release to its evidence. Confirm with your quality function how change control and validation documentation should be structured before the first window is booked.

How DeployOpen works on this

DeployOpen plans, implements, customizes, integrates, hardens, documents and supports self-hosted Drupal inside the client's own infrastructure, including their cloud accounts, data centers or air-gapped networks. For life sciences teams, the work starts with a written scope that separates public brand content from review workflows and any data that should never reach the CMS.

How we scope

Map which markets, languages and brand sites share one Drupal estate and which need separate sites or content ownership.
Document the medical, legal and regulatory review steps, the reviewer roles and the content states each piece passes through.
Define the data boundary so that patient, trial and personal data stay out of the CMS, with the integration points named in writing.

How we build

Build content types, custom modules and themes against the agreed review workflow rather than adding approvals ad hoc later.
Configure multilingual and multisite governance, including which teams may publish to which market sites and under what permissions.
Test accessibility, access control and integration behavior in a staging environment inside your infrastructure before any release.

How we hand over

Deliver written documentation of the content model, workflow states, roles, integrations and deployment steps your team will maintain.
Provide the evidence your own quality and compliance staff need, such as test records, configuration exports and access role lists.
Walk your administrators through updates, backups and release procedures so the site can be operated without us.

How we support

Offer ongoing support, upgrades and continuous testing as a retainer, sized to the scope you agree in writing.
Plan Drupal core and contributed module updates against the published release schedule and the PHP version each release requires.
Confirm with your own compliance team and auditors which controls you need. DeployOpen prepares systems and evidence but does not issue audit reports or certifications.

Drupal for pharmaceutical and life sciences companies